High Tower Advisors, LLC Immunity Bio, Inc. Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 30,095 shares of IBRX stock, worth $101,119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,095
Previous 36,612
17.8%
Holding current value
$101,119
Previous $135,000
42.96%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IBRX
# of Institutions
212Shares Held
70.1MCall Options Held
1.64MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$56.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$38.4 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$29.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$12.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$7.55 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.35B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...